Diseases, Conditions, Syndromes

Orexin receptor 2 agonist improves sleepiness in narcolepsy

For patients with narcolepsy type 1, an orexin receptor 2 agonist, TAK-994, improves measures of sleepiness and cataplexy over eight weeks compared with placebo but is associated with hepatotoxic adverse events, according ...

page 5 from 40